1. Optimisation of TNF-Inhibitor Therapy for Rheumatoid Arthritis: Focus on Certolizumab Pegol

   Events 01 April 2014 Pages: 1 - 1

2. How FABulous is PEGgy? Certoliziumab Pegol from the Bench to the Patients

   • Daniel Aletaha

   Foreword 01 April 2014 Pages: 3 - 4

3. Tumour Necrosis Factor α Antagonists in the Treatment of Rheumatoid Arthritis: An Immunological Perspective

   • Pier-Luigi Meroni
   • Guido Valesini

   Review Article 01 April 2014 Pages: 5 - 13

   

4. Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol

   • Gianfranco Pasut

   Review Article 01 April 2014 Pages: 15 - 23

   

5. Efficacy and Safety of Certolizumab Pegol in Rheumatoid Arthritis: Meeting Rheumatologists’ Requirements in Routine Clinical Practice

   • Leonardo Punzi
   • Giovanni Lapadula
   • Alessandro Mathieu

   Review Article 01 April 2014 Pages: 25 - 37